A Dual‐Targeting Biomimetic Nanoplatform Integrates SDT/CDT/Gas Therapy to Boost Synergistic Ferroptosis for Orthotopic Hepatocellular Carcinoma Therapy
Advanced Science · 2025-02 · 12 (8)
DOI: 10.1002/advs.202413833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 09.01.2025. Verfasst von Wen Meng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Biomedical Materials and Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedica…. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSFC, Fundamental Research Funds for the Central Universities, CAMS Initiative for Innovative Medicine.
Abstract (Originalsprache)
The development of efficient therapeutic strategies to promote ferroptotic cell death offers significant potential for hepatocellular carcinoma (HCC) treatment. Herein, this study presents an HCC‐targeted nanoplatform that integrates bimetallic FeMoO 4 nanoparticles with CO‐releasing molecules, and further camouflaged with SP94 peptide‐modified macrophage membrane for enhanced ferroptosis‐driven multi‐modal therapy of HCC. Leveraging the multi‐enzyme activities of the multivalent metallic elements, the nanoplatform not only decomposes H 2 O 2 to generate oxygen and alleviate tumor hypoxia but also depletes glutathione to inactivate glutathione peroxides 4, which amplify sonodynamic therapy and ferroptotic tumor death under ultrasound (US) irradiation. Meanwhile, the nanoplatform catalyzes the Fenton reaction to produce hydroxyl radicals for chemodynamic therapy. Elevated intracellular reactive oxygen species trigger the cascade release of CO, leading to lethal lipid peroxidation and further enhancing ferroptosis‐mediated tumor therapy. This nanoplatform demonstrates robust anti‐tumor efficacy under US irradiation with favorable biosafety in both subcutaneous and orthotopic HCC models, representing a promising therapeutic approach for HCC. Additionally, the findings offer new insights into tumor microenvironment modulation to optimize US‐triggered multi‐modal cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Biomedical Materials and Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Me…
- Key Laboratory of Bionic Engineering, Ministry of Education, Jilin University, Changchun, 130022, China.
- Department of Hepatobiliary Cancer, Liver Cancer Center, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tianjin's Clinic…
- State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of Education, Frontiers Science Center for Cell Responses, and College of Life Sciences, Nankai University, Tianjin, 30…
ORCID-Profile: Qingqing Xiong, Wen Li
Förderung
- NSFC
- Fundamental Research Funds for the Central Universities
- CAMS Initiative for Innovative Medicine
- the Science and Technology Program of Tianjin, China
- Beijing iGandan Foundation
- National Natural Science Foundation of China
Zitieren
APA
Meng, W., Chen, T., Li, X., Li, Y., Zhang, L., Xu, Y., Song, T., Qi, J., Xiong, Q., & Li, W. (2025). A Dual‐Targeting Biomimetic Nanoplatform Integrates SDT/CDT/Gas Therapy to Boost Synergistic Ferroptosis for Orthotopic Hepatocellular Carcinoma Therapy. Advanced Science, 12(8). https://doi.org/10.1002/advs.202413833
Vancouver
Meng W, Chen T, Li X, Li Y, Zhang L, Xu Y, et al. A Dual‐Targeting Biomimetic Nanoplatform Integrates SDT/CDT/Gas Therapy to Boost Synergistic Ferroptosis for Orthotopic Hepatocellular Carcinoma Therapy. Advanced Science. 2025;12(8). doi:10.1002/advs.202413833
BibTeX
@article{Meng2025,
author = {Meng, Wen and Chen, Ting and Li, Xueping and Li, Yi and Zhang, Lu and Xu, Yigang and Song, Tianqiang and Qi, Ji and Xiong, Qingqing and Li, Wen},
title = {A Dual‐Targeting Biomimetic Nanoplatform Integrates SDT/CDT/Gas Therapy to Boost Synergistic Ferroptosis for Orthotopic Hepatocellular Carcinoma Therapy},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {8},
doi = {10.1002/advs.202413833}
}
EUVIMED